Paratek Pharmaceuticals, Inc.
PRTK
PRTK was delisted on the 20th of September, 2023.
60 hedge funds and large institutions have $264M invested in Paratek Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 13 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
12% less funds holding
Funds holding: 68 → 60 (-8)
24% less capital invested
Capital invested by funds: $346M → $264M (-$82.6M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.96M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$2.64M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.78M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.53M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$1.22M |
| 2 |
Millennium Management
New York
|
-$987K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$757K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$617K |
| 5 |
PP
PDT Partners
New York
|
-$428K |
PRTK Hedge Fund Activity: Q3 2015 in Review
60 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Paratek Pharmaceuticals, Inc. (PRTK) for Q3 2015, worth a combined $264M — down 24% from $346M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PRTK and 5 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 22 added.
The largest buyer was Granahan Investment Management, adding an estimated $4.96M. The largest seller was NEA Management Company, cutting an estimated $1.22M.
- 60 institutional investors held Paratek Pharmaceuticals, Inc. (PRTK) as of Q3 2015, down from 68 in Q2 2015.
- Funds reported $264M of Paratek Pharmaceuticals, Inc. stock for Q3 2015, down 24% quarter-over-quarter.
- 5 funds opened new Paratek Pharmaceuticals, Inc. positions in Q3 2015 and 13 closed out, a net change of -8 holders.
- The largest Paratek Pharmaceuticals, Inc. buyer in Q3 2015 was Granahan Investment Management, an estimated $4.96M added.
- The largest Paratek Pharmaceuticals, Inc. seller in Q3 2015 was NEA Management Company, an estimated $1.22M sold.
Based on aggregated 13F filings for Q3 2015.